Fibromyalgia Resource

Fibromyalgia Information from FibromyalgiaSupport.com
ProHealth Weekly Web Special
HOME Library Bulletins Fibromyalgia Treatment and Research Email bulletins STORE Fibromyalgia Treatment Store Community FibromyalgiaCommunity
Health Watch Newsletter The Latest News Articles The Latest Abstracts The Latest Drug News
Search Our Site
 
Home
Fibromyalgia Resources
E-mail Bulletin
Store
Community
About Us
Your Support Funds Research & Advocacy

Abstract: Harmful impact of EU clinical trials directive: Trial of alerting drug in fibromyalgia has had to be abandoned


Fibromyalgiasupport.com

03-20-2006

Advertisement
BMJ. 2006 Mar 18;332(7542):666.

Hanning CD, Rentowl P.

Leicester General Hospital, Leicester LE5 4PW. chris.hanning@uhl-tr.nhs.uk.

PMID: 16543347 [PubMed - in process]

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study
Rating of 3

Every purchase funds research, donations and the community resources provided within our website.

A culinary gem with health benefits!
First shipments July 3rd, 2008

Ginger Root Neutralizer™

Promote healthy digestion - and more!
First shipments July 3rd, 2008

Peppermint Gels Plus™

A simple remedy for healthy digestion
First shipments July 3rd, 2008

Licorice Relief™

Cleanse & tone your digestive tract with this amazing product
First shipments July 3rd, 2008

Ultra Triphala Complex™

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
 
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community


ProHealth's FibromyalgiaSupport.com- The World's Largest Fibromyalgia Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee